copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Repligen | Inspiring advances in bioprocessing Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of its CTech™ SoloVPE ® PLUS System, the most advanced UV-based Variable Pathlength Technology system now available to biopharmaceutical manufacturers
About Repligen The innovative bioprocessing products manufactured by Repligen are designed to address these important needs of biopharmaceutical manufacturers in an increasingly competitive environment
Products - Repligen Whether you are in fed-batch, hybrid continuous or full continuous mode, or working with therapeutic proteins, gene therapy or vaccines, you can use leading edge solutions from Repligen to streamline your processes and cut your manufacturing costs
Careers - Repligen At Repligen, we provide opportunities for conversation about DEI, offer DEI education resources, encourage allyship, and invest time and energy into developing diverse talent
Leadership - Repligen George A Scott, Jr joined Repligen in April 2024 as Vice President, Global Head of Legal In this role he leads the global legal operations for the Company and drives its strategic direction in support of Repligen’s mission
Repligen Corporation - Press Releases Repligen Corporation to Present at Upcoming November Conferences Download Repligen Corporation to Present at Upcoming November Conferences in PDF format" (opens in new window)
Repligen Store Welcome to the Repligen e-store! Select filtration, chromatography, protein, and analytic products are available for purchase online
News Room - Repligen Stay up-to-date with the latest news from Repligen, including company announcements, product launches, industry insights, and upcoming events Explore how we’re advancing innovation in bioprocessing and shaping the future of therapeutic manufacturing
Repligen Corporation - Investor Relations Investor Relations About Repligen We are a US-based, global developer and manufacturer of highly innovative bioprocessing tools and technologies We provide advanced systems and solutions that enable efficiencies and help set new standards for the way biological drugs are manufactured